- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Oral Calcitonin Tablets, Intranasal Calcitonin, Placebo tablets and placebo intranasal spray
- Drug
- Lead sponsor
- Tarsa Therapeutics, Inc.
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 565 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 9
- States / cities
- Huntsville, Alabama • Oakland, California • Palm Desert, California + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 143
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Osteoporosis, Osteopenia
- Interventions
- melatonin, sugar pill
- Dietary Supplement
- Lead sponsor
- Duquesne University
- Other
- Eligibility
- 45 Years to 54 Years · Female only
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Osteopenia, Osteoporosis, Bone Health in Perimenopausal Women, Menopause Related Conditions, Fracture Healing
- Interventions
- 500 mg calcium from milk-derived minerals, Calcium Carbonate 500 MG
- Other · Dietary Supplement
- Lead sponsor
- Cornell University
- Other
- Eligibility
- 40 Years to 90 Years · Female only
- Enrollment
- 217 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Osteoporosis, Osteopenia or Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Risk, Osteoporotic Fractures, Fragility Fracture, Bone Fracture
- Interventions
- Cortical Bone Mechanics Technology
- Diagnostic Test
- Lead sponsor
- Ohio University
- Other
- Eligibility
- 50 Years to 80 Years · Female only
- Enrollment
- 394 participants
- Timeline
- 2022 – 2023
- U.S. locations
- 5
- States / cities
- Gainesville, Florida • Jacksonville, Florida • Tampa, Florida + 2 more
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Arzoxifene, Raloxifene
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 50 Years to 75 Years · Female only
- Enrollment
- 320 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 5
- States / cities
- Gainesville, Georgia • Urbandale, Iowa • Billings, Montana + 2 more
- Conditions
- Osteoporosis
- Interventions
- ALX1-11
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 91 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 9
- States / cities
- Beverly Hills, California • Chicago, Illinois • Detroit, Michigan + 6 more
- Conditions
- Osteoporosis
- Interventions
- Zoledronic Acid, Placebo
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 68 Years to 90 Years · Female only
- Enrollment
- 2,456 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 30
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • Beverly Hills, California + 26 more
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- Ibandronate [Bonviva/Boniva], Calcium, Vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 55 Years to 80 Years · Female only
- Enrollment
- 1,609 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2004
- U.S. locations
- 20
- States / cities
- Irvine, California • Loma Linda, California • Los Angeles, California + 17 more
- Conditions
- Osteoporotic Fractures, Osteoporosis, Postmenopausal
- Interventions
- Zoledronic acid, vitamin D, calcium, Saline
- Drug · Dietary Supplement · Other
- Lead sponsor
- Susan L. Greenspan
- Other
- Eligibility
- 65 Years and older · Female only
- Enrollment
- 310 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 1
- States / cities
- New Kensington, Pennsylvania
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Romosozumab, Denosumab
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Osteoporosis
- Interventions
- zoledronic acid
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 45 Years to 79 Years · Female only
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • San Diego, California • Denver, Colorado + 15 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- risedronate
- Drug
- Lead sponsor
- Warner Chilcott
- Industry
- Eligibility
- 50 Years and older · Female only
- Enrollment
- 923 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 20
- States / cities
- Birmingham, Alabama • Oakland, California • San Diego, California + 16 more
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Risedronate (HMR4003)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 260 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2004
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Bindex measurement
- Diagnostic Test
- Lead sponsor
- Bone Index Finland Ltd
- Industry
- Eligibility
- 50 Years to 100 Years · Female only
- Enrollment
- 293 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Albuquerque, New Mexico
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Blosozumab
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 2
- States / cities
- Daytona Beach, Florida • Dallas, Texas
- Conditions
- Osteoporosis
- Interventions
- Not listed
- Lead sponsor
- Atlanta VA Medical Center
- Federal
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2012
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Primary Hyperparathyroidism, Bone Diseases, Metabolic, Osteoporosis, Postmenopausal, Bone Loss, Postmenopausal
- Interventions
- Forearm exercise program, Walking program
- Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Low Bone Mass, Osteoporosis, Postmenopausal
- Interventions
- DHEA, Placebo, Exercise
- Other · Behavioral
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 55 Years to 85 Years · Female only
- Enrollment
- 152 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2024
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
- Conditions
- Osteoporosis, Osteopenia, Postmenopausal Osteoporosis
- Interventions
- Moringa Oleifera, Cabbage Placebo
- Dietary Supplement
- Lead sponsor
- Appalachian State University
- Other
- Eligibility
- 60 Years to 70 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Boone, North Carolina
- Conditions
- Breast Cancer, Menopausal Symptoms, Osteoporosis
- Interventions
- raloxifene, quality-of-life assessment
- Drug · Procedure
- Lead sponsor
- OHSU Knight Cancer Institute
- Other
- Eligibility
- Female only
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2003
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Menopausal Osteoporosis
- Interventions
- VSL#3, Placebo
- Drug · Other
- Lead sponsor
- Emory University
- Other
- Eligibility
- 50 Years to 65 Years · Female only
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- LY333334, Placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- Female only
- Enrollment
- 251 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 2
- States / cities
- Daytona Beach, Florida • Honolulu, Hawaii
- Conditions
- Osteoporosis, Postmenopausal, Osteoporosis, Osteoporosis Vertebral, Osteoporosis Risk, Osteoporosis Fracture, Osteoporosis Localized to Spine, Osteoporosis, Age-Related, Osteoporosis Senile, Osteoporosis of Vertebrae
- Interventions
- Abaloparatide
- Drug
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- 50 Years to 85 Years · Female only
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 4
- States / cities
- Golden, Colorado • Gainesville, Georgia • Boston, Massachusetts + 1 more
- Conditions
- Osteoporosis, Osteopenia
- Interventions
- Virtual Bone Biopsy, Teriparatide, Zoledronic Acid
- Other · Drug
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 60 Years and older · Female only
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania